Advertisement

Topics

Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up

17:26 EST 9 Nov 2017 | Reuters

(Reuters) - Dynavax Technologies Corp's hepatitis B vaccine won the U.S. Food and Drug Administration's approval on the third attempt and Chief Executive Eddie Gray told Reuters the company was open to, but not waiting for, a partner to market the dr...

Original Article: Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up

NEXT ARTICLE

More From BioPortfolio on "Dynavax's hepatitis B vaccine gets FDA nod on third try, shares up"

Advertisement
Quick Search
Advertisement
Advertisement